CU22490A1 - PRODUCTION OF THE IRON DEXTRAN COMPLEX FOR ANTI-ANEMIC USE - Google Patents
PRODUCTION OF THE IRON DEXTRAN COMPLEX FOR ANTI-ANEMIC USEInfo
- Publication number
- CU22490A1 CU22490A1 CU1995019A CU1995019A CU22490A1 CU 22490 A1 CU22490 A1 CU 22490A1 CU 1995019 A CU1995019 A CU 1995019A CU 1995019 A CU1995019 A CU 1995019A CU 22490 A1 CU22490 A1 CU 22490A1
- Authority
- CU
- Cuba
- Prior art keywords
- anemic
- production
- iron dextran
- dextran
- dextran complex
- Prior art date
Links
- 230000000567 anti-anemic effect Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940029416 iron-dextran complex Drugs 0.000 title 1
- 229920002307 Dextran Polymers 0.000 abstract 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 abstract 1
- 238000005903 acid hydrolysis reaction Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
- 235000017550 sodium carbonate Nutrition 0.000 abstract 1
- 229910003153 β-FeOOH Inorganic materials 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente solución técnica se relaciona con la rama de la biotecnología teniendo en cuenta el carácter microbial de formación de la dextrana y con la industria farmacéutica al ser un medicamento de uso antianémico y aplicación veterinaria. El procedimiento de fabricación parte de la hidrólisis ácida de la dextrana técnica con el objetivo de disminuir su peso molecular y se utiliza para acomplejar el producto beta-FeOOH formado al mezclar una solución de FeCl3 con Na2CO3. El resultado de la reacción se estabiliza con temperatura constituyendo el fármaco de uso oral.The present technical solution is related to the branch of biotechnology taking into account the microbial nature of dextran formation and to the pharmaceutical industry as it is a medicine for antianemic use and veterinary application. The manufacturing process starts from the acid hydrolysis of the technical dextran with the aim of reducing its molecular weight and is used to complex the beta-FeOOH product formed by mixing a solution of FeCl3 with Na2CO3. The result of the reaction is stabilized with temperature constituting the drug for oral use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1995019A CU22490A1 (en) | 1995-03-01 | 1995-03-01 | PRODUCTION OF THE IRON DEXTRAN COMPLEX FOR ANTI-ANEMIC USE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1995019A CU22490A1 (en) | 1995-03-01 | 1995-03-01 | PRODUCTION OF THE IRON DEXTRAN COMPLEX FOR ANTI-ANEMIC USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU22490A1 true CU22490A1 (en) | 1998-12-30 |
Family
ID=46599236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1995019A CU22490A1 (en) | 1995-03-01 | 1995-03-01 | PRODUCTION OF THE IRON DEXTRAN COMPLEX FOR ANTI-ANEMIC USE |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU22490A1 (en) |
-
1995
- 1995-03-01 CU CU1995019A patent/CU22490A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001849A2 (en) | Novel form of s-omeprazole | |
| BR9406940A (en) | Magnesium-omeprazole process for the preparation of magnesium-omeprazole pharmaceutical composition pharmaceutical formulation for oral administration forum use of magnesium-omeprazole process for the inhibition of gastric acid secretion in mammals and in man and process for the treatment of diseases related to gastric acid in mammals and in men | |
| AU547057B2 (en) | Process for preparing esters of alkanoic acids via rearrangement of alpha-haloketals | |
| ID29050A (en) | MAKING ORGANIC ACID | |
| ES2177993T3 (en) | MANUFACTURE OF ESTERES OF SORBITAN FATTY ACIDS AS TENSIOACTIVE AGENTS. | |
| AR024944A1 (en) | AMIDAS OF CARBOXILIC ACIDS, MEDICATIONS CONTAINING THESE COMPOUNDS, THEIR USE AND THEIR PREPARATION | |
| DE3588095D1 (en) | Polypeptide, its production process and pharmaceutical composition containing it and its use | |
| HUP9900808A2 (en) | Process for producing nucleoside-5'-phosphate | |
| MD20010148A (en) | Process for cultivation of cyanobacteria Spirulina platensis | |
| CA2185189A1 (en) | Process for the production of poly(diorganosiloxanes) with diorganyloxyorganylsilyl or triorganyloxysilyl end groups, crosslinkable mixtures containing them and use thereof | |
| CU22490A1 (en) | PRODUCTION OF THE IRON DEXTRAN COMPLEX FOR ANTI-ANEMIC USE | |
| NO20016381L (en) | Dinukleotidkrystaller | |
| ES8402590A1 (en) | A PROCEDURE FOR PREPARING ANTIBIOTICS FOR 1-AZABICICLO-3.2.0-HEPT-2-ENO. | |
| ES2122219T3 (en) | PROCESS TO PREPARE DIESTERS OF NAFTALENODICARBOXILIC ACIDS. | |
| ATE146185T1 (en) | 11BETA-SUBSTITUTED 14,17-ETHANOESTRATRIENES, METHOD FOR PRODUCING THESE COMPOUNDS AND THEIR USE FOR THE PRODUCTION OF MEDICINAL PRODUCTS | |
| ES8708228A1 (en) | Antipsychotic benzisothiazole S-oxide compound | |
| ES8105034A1 (en) | Istamycins and production thereof | |
| ATE16393T1 (en) | PROCESS FOR THE PRODUCTION OF CHLORINE-PHENYLPHOSPHANES. | |
| ES2067265T3 (en) | PROCEDURE FOR THE PREPARATION IN CONTINUOUS REGIME OF AMINOARIL- OR AMINOALKYL-BETA-SULFATOETILSULFONAS. | |
| RU95103392A (en) | Method of synthesis of 1-hydroxyadamantane | |
| DE59404739D1 (en) | DEXTRANESTER, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE COATING OR EMBEDDING OF MEDICINAL PRODUCTS | |
| GB1343942A (en) | Procedure for obtaining 6-amino-penicillan-acid | |
| ATE372979T1 (en) | HYDROXY BUTTERIC ACID ESTERS OF ACETYLSALICYLIC ACID, THEIR PRODUCTION AND USE AND MEDICINAL PRODUCTS CONTAINING THEM | |
| Reddy et al. | Reaction of 3-Formylchromones with 4-Amino-3-Mercapto-5-Phenyl-4H-1, 2, 4-Triazole Under Phase Transfer Catalysis Conditions-Synthesis of 7-(2′-Hydroxybenzoyl)-3-Phenyl-1, 2, 4-Triazolo [3, 4-b][1, 3,] Thiadiazpins | |
| HUP9803043A2 (en) | Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-azo-9a-homoerythromycin-a, process for preparing them and pharmaceutical compns. contg. them |